AI Article Synopsis
- - A young patient experienced chest pain, and tests indicated possible acute myocarditis.
- - Genetic testing ultimately diagnosed the patient with desmoplakin cardiomyopathy, a specific type of heart disease.
- - It's important to consider desmoplakin cardiomyopathy in cases of recurring myocarditis or if there's a family history of heart issues to prevent misdiagnosis.
Article Abstract
We present a case of a young patient with chest pain. Labs and cardiac imaging were suspicious for acute myocarditis. Genetic testing revealed a diagnosis of desmoplakin cardiomyopathy. Desmoplakin cardiomyopathy may be considered in patients with recurrent acute myocarditis or a family history of cardiac disease to avoid the potential for misdiagnosis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10554-024-03112-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Endurance Exercise Promotes Episodes of Myocardial Injury in Individuals with a Pathogenic Desmoplakin (DSP) Variant.
Heart Rhythm
December 2024
Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Background: Desmoplakin (DSP) variants are associated with left-predominant or biventricular arrhythmogenic cardiomyopathy. Exercise promotes penetrance and sustained ventricular arrhythmias (VA) in right-sided arrhythmogenic right ventricular cardiomyopathy, but its effect is unknown in DSP variant carriers.
Objectives: To assess whether exercise is associated with clinical outcomes among individuals with a pathogenic or likely pathogenic (P/LP) DSP variant.
Four cardiomyopathy patients with a heterozygous DSG2 p.Arg119Ter variant.
Hum Genome Var
December 2024
Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
DSG2, encoding desmoglein-2, is one of the causative genes of arrhythmogenic cardiomyopathy. We previously identified a homozygous DSG2 p.Arg119Ter stop-gain variant in a patient with juvenile-onset cardiomyopathy and advanced biventricular heart failure.
View Article and Find Full Text PDFDesmoplakin cardiomyopathy: a step towards understanding the genetic basis of phenotypic and outcome heterogeneity.
Eur Heart J
December 2024
Institute of Cardiovascular Science, University College London, Rayne Building-Room 228, 5 University Street, London WC1E 6JF, UK.
FDG PET/CT imaging and circulating biomarkers of inflammation in desmoplakin cardiomyopathy.
ESC Heart Fail
December 2024
Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Article Synopsis
- The study aimed to investigate myocardial inflammation in patients with desmoplakin (DSP) cardiomyopathy using FDG PET/CT imaging and assess circulating inflammation biomarkers.
- Ten DSP cardiomyopathy participants and four titin cardiomyopathy participants were recruited; no significant differences in key inflammation markers were found between the groups.
- The results showed some non-specific myocardial FDG uptake in both groups but no overall differences, suggesting similar inflammation profiles in DSP and titin cardiomyopathies.
Unlabelled: Desmosomes are essential cell-cell adhesion organelles that enable tension-prone tissue, like the skin and heart, withstand mechanical stress. Desmosomal anomalies are associated with numerous epidermal disorders and cardiomyopathies. Despite their critical role in maintaining tissue resilience, an understanding of how desmosomes respond to mechanical stimuli is lacking.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!